BKA
AGN

Brick & Kyle Associates’s Allergan plc AGN Stock Holding History

Brick & Kyle Associates’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-315
Closed -$75K – 393
2017
Q1 		$75K Hold
315
– – 0.06% 140
2016
Q4 		$66K Hold
315
– – 0.05% 150
2016
Q3 		$73K Hold
315
– – 0.06% 150
2016
Q2 		$73K Hold
315
– – 0.06% 150
2016
Q1 		$84K Hold
315
– – 0.07% 137
2015
Q4 		$98K Sell
315
-50
-14% -$14.9K 0.09% 122
2015
Q3 		$99K Buy
365
+50
+16% +$15.4K 0.09% 124
2015
Q2 		$96K Buy
315
+60
+24% +$17.9K 0.08% 132
2015
Q1 		$76K Buy
255
+30
+13% +$8.55K 0.07% 144
2014
Q4 		$58K Buy
+225
New +$56.2K 0.05% 164

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Brick & Kyle Associates's AGN Position: Q2 2017 in Review

Brick & Kyle Associates sold out of Allergan plc (AGN) in Q2 2017, closing a stake of 315 shares — an estimated $75K sold.

Brick & Kyle Associates first reported a position in AGN in Q4 2014 and held it in 10 quarters. The position peaked at $99K in Q3 2015. 1,115 funds tracked by Wall St. Rank hold AGN as of Q2 2017.

  • Brick & Kyle Associates reported no remaining Allergan plc position as of Q2 2017 after selling out during the quarter.
  • Brick & Kyle Associates sold 315 Allergan plc shares in Q2 2017, an estimated $75K.
  • Brick & Kyle Associates first reported a position in Allergan plc in Q4 2014 and held it in 10 quarters.
  • Brick & Kyle Associates's Allergan plc position peaked at $99K in Q3 2015.
  • 1,115 funds tracked by Wall St. Rank held Allergan plc as of Q2 2017.

Based on Brick & Kyle Associates's 13F filing for Q2 2017, filed 14 Aug 2017.